Literature DB >> 21368099

The treatment of symptomatic osteoporotic spinal compression fractures.

Stephen I Esses1, Robert McGuire, John Jenkins, Joel Finkelstein, Eric Woodard, William C Watters, Michael J Goldberg, Michael Keith, Charles M Turkelson, Janet L Wies, Patrick Sluka, Kevin M Boyer, Kristin Hitchcock.   

Abstract

This clinical practice guideline is based on a series of systematic reviews of published studies on the treatment of symptomatic osteoporotic spinal compression fractures. Of 11 recommendations, one is strong; one, moderate; three, weak; and six, inconclusive. The strong recommendation is against the use of vertebroplasty to treat the fractures; the moderate recommendation is for the use of calcitonin for 4 weeks following the onset of fracture. The weak recommendations address the use of ibandronate and strontium ranelate to prevent additional symptomatic fractures, the use of L2 nerve root blocks to treat the pain associated with L3 or L4 fractures, and the use of kyphoplasty to treat symptomatic fractures in patients who are neurologically intact.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21368099     DOI: 10.5435/00124635-201103000-00007

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  23 in total

1.  Have levels of evidence improved the quality of orthopaedic research?

Authors:  Brian P Cunningham; Samuel Harmsen; Chris Kweon; Jason Patterson; Robert Waldrop; Alex McLaren; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2013-07-12       Impact factor: 4.176

2.  Vertebroplasty and the placebo response.

Authors:  Franklin G Miller; David F Kallmes; Rachelle Buchbinder
Journal:  Radiology       Date:  2011-06       Impact factor: 11.105

3.  Is vertebroplasty a risk factor for subsequent vertebral fracture, meta-analysis of published evidence?

Authors:  S L Han; S L Wan; Q T Li; D T Xu; H M Zang; N J Chen; L Y Chen; W P Zhang; C Luan; F Yang; Z W Xu
Journal:  Osteoporos Int       Date:  2014-08-23       Impact factor: 4.507

Review 4.  Percutaneous vertebral augmentation in fragility fractures-indications and limitations.

Authors:  O Gonschorek; S Hauck; T Weiß; V Bühren
Journal:  Eur J Trauma Emerg Surg       Date:  2017-01-18       Impact factor: 3.693

Review 5.  Nanotechnology Treatment Options for Osteoporosis and Its Corresponding Consequences.

Authors:  Donglei Wei; Jinsuh Jung; Huilin Yang; David A Stout; Lei Yang
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

6.  Trends in vertebroplasty and kyphoplasty after thoracolumbar osteoporotic fracture: A large database study from 2005 to 2012.

Authors:  Arash Joseph Sayari; Yuzeng Liu; Jeremiah Raphael Cohen; Nicholas Ishmael Van Halm-Lutterodt; Yong Hai; Zorica Buser; Jeffrey Chun Wang
Journal:  J Orthop       Date:  2015-10-27

7.  Re-fracture and correlated risk factors in patients with osteoporotic vertebral fractures.

Authors:  Xinling Ma; Haiou Xia; Jinhua Wang; Xiaoxiao Zhu; Fangyan Huang; Liuxue Lu; Lanyan He
Journal:  J Bone Miner Metab       Date:  2018-11-21       Impact factor: 2.626

8.  Percutaneous vertebroplasty for symptomatic osteoporotic compression fractures: A single-center prospective study.

Authors:  Md Kamrul Ahsan; Om Prakash Pandit; Md Shahidul Islam Khan
Journal:  Surg Neurol Int       Date:  2021-04-19

9.  Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials.

Authors:  S Lou; X Shi; X Zhang; H Lyu; Z Li; Y Wang
Journal:  Osteoporos Int       Date:  2019-08-03       Impact factor: 4.507

10.  Multiple seizure-induced thoracic vertebral compression fractures: a case report.

Authors:  Peter Stilwell; Katherine Harman; William Hsu; Brian Seaman
Journal:  J Can Chiropr Assoc       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.